BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34687742)

  • 41. Consequences of p16 tumor suppressor gene inactivation in mycosis fungoides and Sézary syndrome and role of the bmi-1 and ras oncogenes in disease progression.
    Zhang C; Toulev A; Kamarashev J; Qin JZ; Dummer R; Döbbeling U
    Hum Pathol; 2007 Jul; 38(7):995-1002. PubMed ID: 17442375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting early PKCθ-dependent T-cell infiltration of dystrophic muscle reduces disease severity in a mouse model of muscular dystrophy.
    Lozanoska-Ochser B; Benedetti A; Rizzo G; Marrocco V; Di Maggio R; Fiore P; Bouche M
    J Pathol; 2018 Mar; 244(3):323-333. PubMed ID: 29214629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. STAT3 activation and infiltration of eosinophil granulocytes in mycosis fungoides.
    Fredholm S; Gjerdrum LM; Willerslev-Olsen A; Petersen DL; Nielsen IØ; Kauczok CS; Wobser M; Ralfkiaer U; Bonefeld CM; Wasik MA; Krejsgaard T; Geisler C; Ralfkiaer E; Gniadecki R; Woetmann A; Odum N
    Anticancer Res; 2014 Oct; 34(10):5277-86. PubMed ID: 25275020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of clonal T-cell receptor gamma gene rearrangements with the use of the polymerase chain reaction in cutaneous lesions of mycosis fungoides and Sézary syndrome.
    Bachelez H; Bioul L; Flageul B; Baccard M; Moulonguet-Michau I; Verola O; Morel P; Dubertret L; Sigaux F
    Arch Dermatol; 1995 Sep; 131(9):1027-31. PubMed ID: 7661604
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Staphylococcus aureus Induces Signal Transducer and Activator of Transcription 5‒Dependent miR-155 Expression in Cutaneous T-Cell Lymphoma.
    Willerslev-Olsen A; Gjerdrum LMR; Lindahl LM; Buus TB; Pallesen EMH; Gluud M; Bzorek M; Nielsen BS; Kamstrup MR; Rittig AH; Bonefeld CM; Krejsgaard T; Geisler C; Koralov SB; Litman T; Becker JC; Woetmann A; Iversen L; Odum N
    J Invest Dermatol; 2021 Oct; 141(10):2449-2458. PubMed ID: 33862068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
    Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
    Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
    Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
    Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patch/plaque mycosis-fungoides-like presentations of DUSP22-translocated T-cell lymphomas.
    Runge JS; Novice ML; Briones N; Williams K; Lowe L; Boyer DF; Wilcox RA; Tejasvi T; Hristov AC
    J Cutan Pathol; 2022 Mar; 49(3):299-305. PubMed ID: 34699105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss-of-function phenotype of a PKCθ
    Thuille N; Siegmund K; Klepsch V; Schörgenhuber J; Danklmaier S; Leitges M; Baier G
    Cell Commun Signal; 2019 Nov; 17(1):141. PubMed ID: 31694643
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An Integrated Data Resource for Genomic Analysis of Cutaneous T-Cell Lymphoma.
    Chang LW; Patrone CC; Yang W; Rabionet R; Gallardo F; Espinet B; Sharma MK; Girardi M; Tensen CP; Vermeer M; Geskin LJ
    J Invest Dermatol; 2018 Dec; 138(12):2681-2683. PubMed ID: 29981755
    [No Abstract]   [Full Text] [Related]  

  • 53. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
    LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D
    Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
    J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genome-wide transcriptome analysis of the STAT6-regulated genes in advanced-stage cutaneous T-cell lymphoma.
    Gaydosik AM; Queen DS; Trager MH; Akilov OE; Geskin LJ; Fuschiotti P
    Blood; 2020 Oct; 136(15):1748-1759. PubMed ID: 32438399
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
    Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
    Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Allelotyping in mycosis fungoides and Sézary syndrome: common regions of allelic loss identified on 9p, 10q, and 17p.
    Scarisbrick JJ; Woolford AJ; Russell-Jones R; Whittaker SJ
    J Invest Dermatol; 2001 Sep; 117(3):663-70. PubMed ID: 11564174
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous Lymphomas.
    Vandergriff T; Nezafati KA; Susa J; Karai L; Sanguinetti A; Hynan LS; Ambruzs JM; Oliver DH; Pandya AG
    J Cutan Pathol; 2015 May; 42(5):318-28. PubMed ID: 25721994
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T-cell receptor gene rearrangement in canine mycosis fungoides: further support for a canine model of cutaneous T-cell lymphoma.
    Fivenson DP; Saed GM; Beck ER; Dunstan RW; Moore PF
    J Invest Dermatol; 1994 Feb; 102(2):227-30. PubMed ID: 7906287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcriptomic changes during stage progression of mycosis fungoides.
    Xiao MZX; Hennessey D; Iyer A; O'Keefe S; Zhang F; Sivanand A; Gniadecki R
    Br J Dermatol; 2022 Mar; 186(3):520-531. PubMed ID: 34528236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.